文献速递炎症性肠病

人1型调节性T细胞的抑制与肠道修复功能

Suppressive and Gut-Reparative Functions of Human Type 1 T Regulatory Cells.
PubMed 文献 · Gastroenterology · 2019-09-10

该研究从克罗恩病、溃疡性结肠炎患者及健康对照者外周血和结肠活检样本中分离并扩增人1型调节性T细胞(Tr1),发现Tr1与FOXP3阳性Treg均能抑制效应T细胞增殖,但仅Tr1能抑制髓系细胞分泌IL1B和TNF,并分泌IL22促进肠上皮屏障功能及杯状细胞分化。

要点

  • Tr1细胞抑制效应T细胞增殖及髓系细胞产生IL1B和TNF。
  • Tr1细胞分泌IL22促进人肠上皮细胞屏障功能。
  • Tr1细胞上清促进肠类器官中产黏蛋白杯状细胞分化。

核心结论

  • 人Tr1细胞抑制适应性免疫(效应T细胞增殖)和固有免疫(髓系细胞产生IL1B和TNF),并分泌IL22促进屏障功能,可能开发为肠道炎症性疾病的细胞疗法。

研究设计与样本

  • 获取克罗恩病、溃疡性结肠炎患者及健康对照者的血液和结肠活检样本,分离CD4+ T细胞,经抗CD3/抗CD28磁珠刺激后用IL10细胞因子捕获法和流式分选纯化Tr1细胞。
  • 从非刺激细胞中分选CD4+CD25highCD127low的FOXP3阳性Treg细胞,扩增后比较Tr1与FOXP3阳性Treg的表型和基因表达谱。
  • 用健康供者外周血单个核细胞中的T细胞经抗CD3/抗CD28磁珠刺激,测定Tr1与FOXP3阳性Treg的抑制能力。
  • 建立人结肠类器官培养,与Tr1或FOXP3阳性细胞上清共培养后用免疫荧光和流式细胞术分析。
  • 将T84人结肠腺癌细胞与Tr1或FOXP3阳性细胞上清孵育,测量跨上皮电阻以评估上皮细胞屏障功能。

主要发现

  • 扩增后,健康对照者与克罗恩病或溃疡性结肠炎患者来源的Tr1细胞表型无显著差异。
  • Tr1细胞和FOXP3阳性Treg细胞均抑制效应T细胞增殖,但仅Tr1细胞抑制髓系细胞分泌IL1B和肿瘤坏死因子。
  • 来自健康个体及克罗恩病或溃疡性结肠炎患者的Tr1细胞(而非FOXP3阳性Treg细胞)分泌IL22,促进人肠上皮细胞屏障功能。
  • Tr1细胞培养上清促进肠道类器官培养中产黏蛋白杯状细胞的分化。

临床怎么用

  • Tr1细胞可能作为肠道炎症性疾病的细胞治疗候选,其抑制固有免疫和促进屏障修复的特性区别于FOXP3阳性Treg。
  • 患者来源Tr1细胞扩增后表型与健康对照无显著差异,支持自体Tr1细胞治疗的可行性探索。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: T-regulatory (Treg) cells suppress the immune response to maintain homeostasis. There are 2 main subsets of Treg cells: FOXP3 (forkhead box protein 3)-positive Treg cells, which do not produce high levels of effector cytokines, and type 1 Treg (Tr1) cells, which are FOXP3-negative and secrete interleukin (IL) 10. IL10 is an anti-inflammatory cytokine, so Tr1 cells might be used in the treatment of inflammatory bowel diseases. We aimed to develop methods to isolate and expand human Tr1 cells and define their functions. METHODS: We obtained blood and colon biopsy samples from patients with Crohn's disease or ulcerative colitis or healthy individuals (controls). CD4+ T cells were isolated from blood samples and stimulated with anti-CD3 and anti-CD28 beads, and Tr1 cells were purified by using an IL10 cytokine-capture assay and cell sorting. FOXP3-positive Treg cells were sorted as CD4+CD25highCD127low cells from unstimulated cells. Tr1 and FOXP3-positive Treg cells were expanded, and phenotypes and gene expression profiles were compared. T cells in peripheral blood mononuclear cells from healthy donors were stimulated with anti-CD3 and anti-CD28 beads, and the suppressive abilities of Tr1 and FOXP3-positive Treg cells were measured. Human colon organoid cultures were established, cultured with supernatants from Tr1 or FOXP3-positive cells, and analyzed by immunofluorescence and flow cytometry. T84 cells (human colon adenocarcinoma epithelial cells) were incubated with supernatants from Tr1 or FOXP3-positive cells, and transepithelial electrical resistance was measured to determine epithelial cell barrier function. RESULTS: Phenotypes of Tr1 cells isolated from control individuals vs patients with Crohn's disease or ulcerative colitis did not differ significantly after expansion. Tr1 cells and FOXP3-positive Treg cells suppressed proliferation of effector T cells, but only Tr1 cells suppressed secretion of IL1B and tumor necrosis factor from myeloid cells. Tr1 cells, but not FOXP3-positive Treg cells, isolated from healthy individuals and patients with Crohn's disease or ulcerative colitis secreted IL22, which promoted barrier function of human intestinal epithelial cells. Tr1 cell culture supernatants promoted differentiation of mucin-producing goblet cells in intestinal organoid cultures. CONCLUSIONS: Human Tr1 cells suppress proliferation of effector T cells (adaptive immune response) and production of IL1B and TNF by myeloid cells (inmate immune response). They also secrete IL22 to promote barrier function. They might be developed as a cell-based therapy for intestinal inflammatory disorders.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Cook L, Stahl M, Han X, et al. Suppressive and Gut-Reparative Functions of Human Type 1 T Regulatory Cells. Gastroenterology. 2019. PMID: 31513797. doi:10.1053/j.gastro.2019.09.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。